반응식
[NH:1]1[C:10]2[CH2:9][CH2:8][CH2:7][CH2:6][NH:5][C:4]=2[CH:3]=[CH:2]1.[C:11]([O:15][C:16]([N:18]1[CH2:22][CH2:21][CH2:20][C@H:19]1[C:23](Cl)=[O:24])=[O:17])([CH3:14])([CH3:13])[CH3:12]>C(Cl)Cl>[C:11]([O:15][C:16]([N:18]1[CH2:22][CH2:21][CH2:20][C@H:19]1[C:23]([N:5]1[CH2:6][CH2:7][CH2:8][CH2:9][C:10]2[NH:1][CH:2]=[CH:3][C:4]1=2)=[O:24])=[O:17])([CH3:14])([CH3:13])[CH3:12]참가 물질
반응물 2
생성물 1
시약·촉매·용매 1
실험 절차
To a solution of(S)-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester (664 mg) in DCM (10 mL) at 0° C. was added oxalyl chloride (4.7 mmol), followed by one drop of DMF. After stirring at rt for 2 hours, the solvent was concentrated to give S) 2-chlorocarbonyl-pyrrolidine-1-carboxylic acid tert-butyl ester. To a solution of 1,4,5,6,7,8-hexahydro-pyrrolo[3,2-b]azepine (350 mg, 2.6 mmol) was added TEA (362 μL) and (S)-2-chlorocarbonyl-pyrrolidine-1-carboxylic acid tert-butyl ester (dissolved in 10 mL of DCM). After stirring at rt for overnight, the reaction was diluted with DCM, washed with NaHCO3, brine, dried and concentrated. The residue was purified on a silica gel column to give 410 mg of (S)-2-(5,6,7,8-tetrahydro-1H-pyrrolo[3,2-b]azepine-4-carbonyl)-pyrrolidine-1-carboxylic-acid tert-butyl ester as a light brown liquid.
후처리
- washwashed with NaHCO3, brine
- customdried
- concentrationconcentrated
- customThe residue was purified on a silica gel column
출처 및 근거
- ORD 기록
- ord-d33a4ec1f8004256b23ff28a66588708
- 출처 데이터셋
- uspto-grants-2005_03
- 특허 번호
- US06861418B2
연결된 노트
불러오는 중…